CPC Scientific
CPC Scientific is a CRDMO specializing in synthetic peptides and oligonucleotides, serving pharmaceutical, biotechnology, academic, cosmetic, and generic drug manufacturers globally through custom research, GMP manufacturing, and commercial API production across 50+ countries.
- Company typePrivate
- Founded2001
- HeadquartersRocklin, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What CPC Scientific does
CPC Scientific is a Contract Research, Development, and Manufacturing Organization (CRDMO) founded in 2001 and headquartered in Rocklin, California, with primary GMP manufacturing operations in Hangzhou, China, through its Chinese Peptide Company subsidiary. The company is a wholly owned subsidiary of Hong Kong-listed Medtide Inc. (HKEX: 03880), which completed its IPO in June 2025. CPC Scientific specializes in synthetic peptide and oligonucleotide production, with core technical capabilities spanning Solid-Phase Peptide Synthesis (Fmoc, Boc, Cbz), Liquid-Phase Synthesis, ligation chemistry, and peptide-oligonucleotide conjugates including POCs, PDCs, and RDCs. It maintains 26,000 sqm of GMP manufacturing infrastructure with 19 synthesis suites, 16 purification suites, reactor volumes up to 1,000L, and an annual API capacity exceeding 1,000 kg at 20-25 kg per batch.
The company's product and service portfolio spans the full peptide lifecycle: custom research-grade peptide synthesis, a 1,200+ sequence catalog across 21 research areas, FTE-based discovery services, GMP peptide manufacturing for Phase I through commercial supply, GMP oligonucleotide manufacturing (1-17 kg annual capacity), generic peptide API development (Leuprorelin, Triptorelin, Cetrorelix, Goserelin, Teduglutide), cosmetic peptides, neoantigen peptides, and a broad peptide modifications portfolio (macrocycles, stapled peptides, PEGylated, dye-labeled, glycosylated, click, peptoids, long sequences, D-amino acids, isotope-labeled). Regulatory credentials include FDA DMFs for Tirzepatide (DMF 043979, May 2026) and Cetrorelix (DMF 034884), five successful FDA inspections, and certifications from EMA, TGA, MFDS, NMPA, and three ISO standards.
CPC Scientific operates an enterprise field-sales model supplemented by industry conference presence (CPHI Frankfurt/Korea/Milan, TIDES Europe, BioJapan, DCAT), direct quotation-based GMP sales, an e-commerce catalog for research peptides, and FedEx international shipping across 50+ countries. Customer segments span pharmaceutical companies, biotechnology companies, academic and research institutions, cosmetics companies, and generic drug manufacturers, with 300+ ongoing CMC development projects and 13 commercial GMP programs as of 2025. Revenue is generated through one-time custom and catalog purchases, multi-year managed GMP manufacturing contracts, FTE-based professional services, and commercial API licensing, though specific revenue figures are not publicly disclosed.
CPC Scientific firmographics
Firmographics- Name
- CPC Scientific
- Legal name
- CPC Scientific Inc.
- Website
- https://cpcscientific.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CPC Scientific is a CRDMO specializing in synthetic peptides and oligonucleotides, serving pharmaceutical, biotechnology, academic, cosmetic, and generic drug manufacturers globally through custom research, GMP manufacturing, and commercial API production across 50+ countries.
- Ownership category
- akta.pro rank
CPC Scientific industry classification
Industry- Product category
- Contract Peptide and Oligonucleotide Manufacturing (CRDMO)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industries
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where CPC Scientific is headquartered
LocationHeadquarters
- HQ city
- Rocklin
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
CPC Scientific business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Custom Peptide Synthesis Services: CRO services including peptide NCE discovery synthesis and custom peptide manufacturing for research purposes
- GMP Peptide Manufacturing (CDMO): Contract development and manufacturing services for peptide CMC development, late-phase development, and commercial production under GMP conditions
- Commercial API Manufacturing (CMO): Contract manufacturing for peptide NCE and generic drug commercial production, including regulatory filing support (DMF preparation)
- Catalog Peptide Sales: Sale of pre-made catalog peptides (1,200+ sequences across 21 research areas) with pricing from $16.50 to $1,386+ per unit
- FTE (Full-Time Equivalent) Services: Discovery chemistry services providing dedicated scientific staff allocation for flexible, continuous project support
- Generic Peptide APIs: Commercial generic peptide API manufacturing for approved indications including cancer, diabetes, obesity, and multiple sclerosis treatments
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog peptides available in various sizes (mg to multi-mg) |
| Other | Multi-year contract | FTE Model for discovery chemistry services |
| Other | Multi-year contract | GMP Manufacturing Services |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
CPC Scientific product offering
Product offeringCore offering
CPC Scientific is a Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end synthetic peptide and oligonucleotide services to pharmaceutical and biotechnology companies. Its core offerings span custom research peptide synthesis and catalog peptide sales, peptide modifications (macrocycles, stapled peptides, PEGylation, glycosylation, etc.), Phase I–III and commercial GMP peptide manufacturing, generic peptide API production, GMP oligonucleotide manufacturing, and integrated peptide-oligonucleotide conjugates (POC/PDC/RDC).
Product overview
CPC Scientific is a Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in synthetic peptides and oligonucleotides. The company operates as a single integrated platform offering end-to-end services from discovery through commercial manufacturing. The core product portfolio centers on GMP Peptide Manufacturing (including Phase I-III and commercial GMP programs), Research Peptides (custom synthesis and catalog offerings with 1,200+ sequences), and GMP Oligonucleotide Manufacturing. These are supplemented by Peptide-Oligonucleotide Conjugates, Generic Peptides API Development, Cosmetic Peptides, Neoantigen Peptides, FTE Services, and a comprehensive Peptide Modifications Portfolio covering macrocycles, stapled peptides, PEGylation, dye-labeling, and other specialized modifications. The platform is vertically integrated to support pharmaceutical and biotech partners across the entire therapeutic lifecycle.
Differentiator
Problem solved
Functional benefit
Products and services
- GMP Peptide Manufacturing Large-scale, late-phase, and commercial GMP peptide manufacturing services with annual API production capacity over 1,000 kg and per-batch capacity of 20–25 kg. Supports projects from early discovery through commercialization with CGMP compliance for NMPA, FDA, EMA, TGA, and MFDS regulatory authorities. For pharmaceutical and biotechnology clients.
- Custom Peptide Synthesis (Research Peptides) Custom peptide synthesis services providing reliable, high-quality peptides directly to researchers and institutions, including complex modifications (macrocycles, stapled peptides, dye-labeled, PEGylated, click, glycosylated, phosphorylated, peptoids, unnatural amino acids, peptide libraries, lipopeptides, multiple disulfide bridges, long sequences, D-amino acids, isotope labeled). Includes a 1,200+ catalog of pre-made peptides across 21 research areas.
- GMP Oligonucleotide Manufacturing Research-grade and clinical-grade oligonucleotide manufacturing services spanning from discovery to clinical phases, with recently reconfigured capacity for 1–17 kilograms of oligonucleotides annually.
- Peptide-Oligonucleotide Conjugates Seamlessly integrates peptide and oligonucleotide platforms to produce peptide conjugates including peptide-oligonucleotide conjugates (POC), peptide drug conjugates (PDC), and radionuclide drug conjugates (RDC).
- Generic Peptide API Development Commercial generic API manufacturing including Leuprorelin Acetate, Triptorelin Acetate, Cetrorelix Acetate, Goserelin Acetate, Triptorelin Pamoate, and Teduglutide for treatment of cancer, diabetes, obesity, and multiple sclerosis.
- Cosmetic Peptides Cosmetic peptide ingredient synthesis for anti-aging, wound healing, and skin care applications. Manufacturing capacity ranges from mg quantities through 100 kg commercialization scale, with ISO 22716 GMP compliance.
- Neoantigen Peptides Custom neoantigen peptide synthesis services for personalized therapeutic applications.
- FTE Services Full-time equivalent (FTE) based discovery chemistry services for synthetic peptides, providing dedicated scientific support with flexible resource allocation and continuous project engagement.
Quantifiable outcome
- 300+ ongoing CMC development projects supported
- +4 more outcomes
Companies that use CPC Scientific
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
CPC Scientific technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
CPC Scientific partnerships and signals
Strategic signalScale indicators12 records
Recent moves7 records
Expansion highlights5 records
CPC Scientific competitors and assessment
Company assessmentDirect peers
- CordenPharma: Global CDMO with a dedicated peptide platform offering custom synthesis, GMP manufacturing, and generic peptide APIs across multiple sites—competes head-to-head with CPC for both commercial peptide API and complex modification projects.
- WuXi STA (WuXi AppTec): China-based CRDMO with a major peptide and oligonucleotide franchise plus much broader small molecule and biologic capabilities—directly comparable to CPC's peptide CRDMO model while also competing on geographic flexibility and scale.
- PolyPeptide Group: Public peptide CDMO offering custom and GMP-grade peptides for pharma and biotech, with comparable end-to-end capabilities across APIs, generic peptides, and complex modifications—directly competes with CPC for the same customer profile.
- Senn Chemicals: Swiss peptide CDMO offering custom peptide synthesis, GMP production, and a generic peptide API portfolio—directly comparable to CPC's discovery-through-commercial peptide services for pharma and biotech customers.
- Bachem: Swiss-headquartered global leader in peptide and oligonucleotide CDMO services with large-scale GMP manufacturing, extensive DMF portfolio, and a similar end-to-end offering from custom synthesis through commercial API production—CPC's most direct competitor in peptide API.
- Avecia (Nitto Denko Avecia): Specialist oligonucleotide CDMO offering custom and GMP oligo manufacturing—directly comparable to CPC's recently expanded GMP oligonucleotide platform and peptide-oligonucleotide conjugate capability.
- AmbioPharm: US- and China-based peptide CDMO specializing in custom peptide synthesis, GMP manufacturing, and generic peptide APIs—closely comparable to CPC across both research and commercial peptide manufacturing.
Broad incumbents
- Lonza: Largest global CDMO with a peptide and small-molecule API platform alongside biologics, cell & gene, and other modalities—overlaps with CPC on peptide CMC and commercial API but operates at far greater scale and modality breadth.
Emerging players
- Syngene International: India-based integrated CRDMO with peptide, small molecule, and biologics capabilities—competes with CPC for biotech CDMO contracts, particularly for customers seeking alternative geographic supply outside US/EU/China.
- GenScript ProBio: CDMO arm of GenScript offering peptide synthesis, biologics, plasmid, and cell therapy services with growing GMP capacity—an emerging player whose peptide services increasingly compete with CPC for biotech customers in Asia and globally.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CPC Scientific social profiles
Digital presenceCPC Scientific compliance and trust
Trust signalCompliance8 records
CPC Scientific financial estimates
Financial estimateRevenue estimate
Valuation estimate
CPC Scientific leadership team
Management profileNumber of profiles
Profiles5 records
CPC Scientific funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CPC Scientific M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CPC Scientific
What does CPC Scientific do?
CPC Scientific is a Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end synthetic peptide and oligonucleotide services to pharmaceutical and biotechnology companies. Its core offerings span custom research peptide synthesis and catalog peptide sales, peptide modifications (macrocycles, stapled peptides, PEGylation, glycosylation, etc.), Phase I–III and commercial GMP peptide manufacturing, generic peptide API production, GMP oligonucleotide manufacturing, and integrated peptide-oligonucleotide conjugates (POC/PDC/RDC).
Is CPC Scientific a public or private company?
CPC Scientific is a private company. It is classified as corporate owned and is currently operating.
When was CPC Scientific founded?
CPC Scientific was founded in 2001. It employs 501 to 1,000 people.
Where is CPC Scientific based?
CPC Scientific is headquartered in Rocklin, United States, in the North America region.
How does CPC Scientific make money?
Six revenue lines are on record. Custom Peptide Synthesis Services are the primary driver. The others are GMP Peptide Manufacturing (CDMO), commercial API Manufacturing (CMO), catalog Peptide Sales, FTE (Full-Time Equivalent) Services and generic Peptide APIs.
Who are CPC Scientific's main competitors?
Direct peers on record are CordenPharma, WuXi STA (WuXi AppTec), PolyPeptide Group, Senn Chemicals, Bachem, Avecia (Nitto Denko Avecia) and AmbioPharm. Lonza is listed as a broad incumbent. Emerging players are Syngene International and GenScript ProBio.
Does CPC Scientific have an API?
No public API is recorded for CPC Scientific.
What industry is CPC Scientific in?
CPC Scientific's product category is Contract Peptide and Oligonucleotide Manufacturing (CRDMO). Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 541714 and its SIC code is 8731.